Log in

NASDAQ:MGENMiragen Therapeutics Insider Trades

-0.05 (-4.50 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $1.06
50-Day Range
MA: $0.93
52-Week Range
Now: $1.06
Volume880,655 shs
Average Volume3.39 million shs
Market Capitalization$56.26 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Miragen Therapeutics (NASDAQ:MGEN) Insider Buying and Selling Activity

Insider Ownership Percentage: 3.00%

Insider Buying and Selling by Quarter

Miragen Therapeutics (NASDAQ MGEN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2018Thomas E HughesDirectorBuy10,000$4.77$47,700.0012,827  
2/13/2018Adam Scott LevyInsiderBuy9,090$5.50$49,995.0010,540  
2/13/2018Bruce BoothDirectorBuy545,454$5.50$2,999,997.00  
12/20/2017Thomas E. HughesDirectorSell12,000$8.00$96,000.00  
6/22/2017Adam Scott LevyInsiderBuy200$7.55$1,510.00200  
3/10/2017Kyle LefkoffDirectorSell5,800$14.34$83,172.00  
3/8/2017Kyle LefkoffDirectorSell15,000$15.40$231,000.00  
2/28/2017Kyle LefkoffDirectorSell10,258$13.89$142,483.62  
2/23/2017Kyle LefkoffDirectorSell5,902$14.14$83,454.28  
11/20/2015Samuel D. RiccitelliCEOBuy14,000$0.79$11,060.00345,130  
(Data available from 1/1/2013 forward)
This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.